Quantifying the Long-Run Economic and Health Impact of Reduced Intellectual Property Protections for New Drugs
Healthcare ECONOMIST
MAY 30, 2023
Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical technologies, particularly in Eastern Europe and developing countries.
Let's personalize your content